HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-dose doxepin: in the treatment of insomnia.

Abstract
Doxepin binds with high specificity and affinity to the histamine H(1) receptor compared with other receptors. Therefore, at low doses, doxepin selectively antagonises H(1) receptors, which is believed to promote the initiation and maintenance of sleep. In three large, well designed, phase III trials in adult or elderly patients with chronic primary insomnia, oral, low-dose doxepin 3 or 6 mg once daily improved wake time after sleep onset, total sleep time and sleep efficiency to a significantly greater extent than placebo. Significant between-group differences in polysomnographic sleep recordings that favoured low-dose doxepin were evident after a single administration of the drug. Other efficacy measures, including patient-reported sleep quality, also favoured low-dose doxepin over placebo. Symptom control was maintained for up to 12 weeks of low-dose doxepin administration and there was no evidence of physical dependence or worsening insomnia after doxepin withdrawal. Oral, low-dose doxepin 6 mg was also significantly more effective than placebo in a large, well designed trial modelling transient insomnia in healthy adults, according to polysomnographic recordings (e.g. in latency to persistent sleep). Oral, low-dose doxepin was generally well tolerated in clinical trials.
AuthorsJuliane Weber, M Asif A Siddiqui, Antona J Wagstaff, Paul L McCormack
JournalCNS drugs (CNS Drugs) Vol. 24 Issue 8 Pg. 713-20 (Aug 2010) ISSN: 1179-1934 [Electronic] New Zealand
PMID20658801 (Publication Type: Journal Article, Review)
Chemical References
  • Antidepressive Agents, Tricyclic
  • Doxepin
Topics
  • Adult
  • Antidepressive Agents, Tricyclic (adverse effects, pharmacokinetics, pharmacology, therapeutic use)
  • Clinical Trials as Topic
  • Doxepin (administration & dosage, adverse effects, pharmacokinetics, pharmacology)
  • Female
  • Humans
  • Male
  • Sleep Initiation and Maintenance Disorders (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: